Evidence map›Paper›PMID 35126917›Full record

ArticleJournal of healthcare engineering2022

The Exosomes Containing LINC00461 Originated from Multiple Myeloma Inhibit the Osteoblast Differentiation of Bone Mesenchymal Stem Cells via Sponging miR-324-3p.

Yang Wu, Zhemei Zhang, Jing Wu, Jinxia Hou, Guosheng Ding

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Advances in the pathogenesis of multiple myeloma bone disease.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yang WuClinical Laboratory Center, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China.
Zhemei ZhangClinical Laboratory Center, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China.
Jing WuClinical Laboratory Center, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China.
Jinxia HouClinical Laboratory Center, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China.
Guosheng DingClinical Laboratory Center, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China.ORCID 0000-0002-5696-4664
Gansu Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma is one of the hematological malignancies and inhibited osteoblast differentiation of bone marrow mesenchymal stem cells (BM-MSCs) which has been proved as a major complication of the patients with multiple myeloma. However, the pathomechanism of symptom remains unclear. Besides, several studies have indicated that LINC00461 plays an important role in the progression of multiple tumors. Hence, this study attempted to reveal the role of LINC00461 in the osteoblast differentiation of MSCs. In this study, the expression level of LINC00461 in the exosomes of multiple myeloma cells was measured, and BM-MSCs were cultured with the exosomes to observe the change of cellular phenotype. Moreover, downstream target of LINC00461 was searched and verified with dual-luciferase reporter assay, and the activation of the Wnt/

Indexed as

ExosomesMesenchymal Stem CellsMicroRNAsMultiple Myelomabeta CateninHumansOsteoblastsRNA, Long Noncodingbeta CateninLINC00461 lncRNA, humanMicroRNAsMIRN324 microRNA, humanRNA, Long Noncoding

Identifiers

PMID35126917
PMCPMC8808147
OpenAlexW4210597410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.